MyFinsight
Home
Blog
About
Cash and cash
equivalents
$26,094K
(-54.90%↓ Y/Y)
Prepaid materials
$3,013K
(-13.29%↓ Y/Y)
Prepaid expenses and
other current assets
$1,793K
(66.79%↑ Y/Y)
Restricted cash
$110K
(0.00%↑ Y/Y)
Total current assets
$31,010K
(-50.40%↓ Y/Y)
Other assets
$1,271K
(-36.39%↓ Y/Y)
Total assets
$32,281K
(-49.96%↓ Y/Y)
Total liabilities and
stockholders' equity
$32,281K
(-49.96%↓ Y/Y)
Total stockholders'
equity
$26,830K
(-53.50%↓ Y/Y)
Total liabilities
$5,451K
(-20.07%↓ Y/Y)
Accumulated deficit
-$264,642K
(-16.62%↓ Y/Y)
Treasury stock, at cost
88,003 shares of common...
$1,475K
(0.00%↑ Y/Y)
Additional paid-in capital
$291,151K
(10.87%↑ Y/Y)
Total current
liabilities
$5,451K
(-20.07%↓ Y/Y)
Common stock - 0.18 par
value 350,000,000...
$1,796K
(-92.35%↓ Y/Y)
Accounts payable
$1,976K
(-1.69%↓ Y/Y)
Accrued expenses
$1,380K
(-37.27%↓ Y/Y)
Other current
liabilities
$1,123K
(-27.83%↓ Y/Y)
Payroll liabilities
$972K
(-7.78%↓ Y/Y)
Back
Back
Balance Sheet
ATOSSA THERAPEUTICS, INC. (ATOS)
ATOSSA THERAPEUTICS, INC. (ATOS)
source: myfinsight.com